Emergence of Artificial Intelligence in Multiple Domains of Neurology: A Review
DOI:
https://doi.org/10.14738/bjhr.1302.20164Abstract
Artificial Intelligence (AI) has emerged as a transformative force across multiple domains of neurology, reshaping traditional paradigms in diagnosis, therapeutics, research, and patient care. This review explores the breadth and depth of AI applications within neurological sciences, emphasizing clinical innovations, translational potential, and ethical implications. In diagnostics, AI has significantly enhanced neuroimaging interpretation, disease classification, and multimodal data integration—enabling earlier and more accurate detection of conditions such as Alzheimer’s disease, stroke, and Parkinson’s disease. Therapeutically, AI-driven adaptive deep brain stimulation (aDBS) and closed-loop neuromodulation systems are setting new standards for personalized treatment, offering dynamic feedback-based modulation of neural activity. The review also addresses AI’s critical role in drug discovery and development, where deep learning and generative models have accelerated target identification, virtual screening, and molecule generation. Assistive technologies, particularly brain–computer interfaces (BCIs), have advanced rapidly, enabling communication and mobility for individuals with profound neurological disabilities. These innovations include speech prostheses, silent-speech decoding, and robotic sensory feedback systems. Despite these advancements, the integration of AI in neurology faces challenges including data bias, explainability, and privacy concerns. The future of AI-driven neurology will depend on interdisciplinary collaboration, ethical governance, and the continued development of interpretable, equitable, and human-centered technologies. This review synthesizes current progress while mapping trajectories for future research and clinical implementation.
References
Abramson, J., et al. (2024). Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature.
Birbaumer, N., et al. (1999). A spelling device for paralysis. Nature, 398, 297–298.
Björnsson, B., Borrebaeck, C., Elander, N., et al. (2020). Digital twins to personalize medicine. Genome Medicine, 12, 4.
Blanco-González, A., et al. (2023). Artificial intelligence in drug discovery: Opportunities and challenges. Pharmaceuticals, 16(2), 215.
Bösel, J., Mathur, R., Cheng, L., et al. (2025). AI and neurology. Neurological Research and Practice, 7, 11. https://doi.org/10.1186/s42466-025-00367-2
Chaudhary, U., Birbaumer, N., & Ramos-Murguialday, A. (2016). Brain–computer interfaces for communication and rehabilitation. Nature Reviews Neurology, 12, 513–525.
Comanducci, A., Boly, M., Claassen, J., De Lucia, M., Gibson, R. M., Juan, E., Laureys, S., Naccache, L., Owen, A. M., Rosanova, M., & Schiff, N. D. (2020). Clinical and advanced Scholar Publishing neurophysiology in disorders of consciousness: A systematic review. Neurology, 95(3), 124–134. https://doi.org/10.1212/WNL.0000000000009828
Corazzol, M., Lio, G., Lefevre, A., et al. (2017). Restoring consciousness with vagus nerve stimulation. Current Biology, 27(18), R994–R996.
Denys, D., Mantione, M., Figee, M., et al. (2010). Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Archives of General Psychiatry, 67(10),
Doshi-Velez, F., & Kim, B. (2017). Towards a rigorous science of interpretable machine learning. arXiv preprint arXiv:1702.08608.
Duvenaud, D. K., et al. (2015). Convolutional networks on graphs for learning molecular fingerprints. Advances in Neural Information Processing Systems.
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118. https://doi.org/10.1038/nature21056
European Commission. (2019). Ethics guidelines for trustworthy AI. European Commission. European Medicines Agency (EMA). (2020). Reflection paper on the use of artificial intelligence in the medicinal product lifecycle. EMA.
European Parliament & Council of the European Union. (2016). Regulation (EU) 2016/679 (General Data Protection Regulation). Official Journal of the European Union.
Fang, J., et al. (2022). Artificial intelligence in neurodegenerative disease research. Frontiers in Neuroscience, 16, 1034105.
Flesher, S. N., et al. (2016). Intracortical microstimulation of human somatosensory cortex. Science Translational Medicine, 8(361).
Fomenko, A., Neudorfer, C., Dallapiazza, R. F., et al. (2018). Low-intensity ultrasound neuromodulation: An overview of mechanisms and emerging human applications. Brain Stimulation, 11(6), 1209–1217.
Frey, J. (2016). Comparison of an open-hardware EEG amplifier with medical grade device. Frontiers in Neuroscience, 10, 530.
Goodfellow, I., Bengio, Y., & Courville, A. (2016). Deep learning. MIT Press.
Goodfellow, I., et al. (2014). Generative adversarial nets. Advances in Neural Information Processing Systems.
Guger, C., et al. (2009). How many people are able to control a P300-based BCI? Neuroscience Letters, 462, 94–98.
Haddock, A., Mitchell, K. T., Miller, A., et al. (2022). Automated deep brain stimulation programming using machine learning. Neuromodulation, 25(4), 512–520.
Ho, J., Jain, A., & Abbeel, P. (2020). Denoising diffusion probabilistic models. Advances in Neural Information Processing Systems, 33, 6840–6851.
Hochberg, L. R., et al. (2012). Reach and grasp by people with tetraplegia using neural prosthetics. Nature, 485, 372–375.
Holtzheimer, P. E., Husain, M. M., Lisanby, S. H., et al. (2017). Subcallosal cingulate deep brain stimulation for treatment-resistant depression: A multisite, randomized, sham-controlled trial. The Lancet Psychiatry, 4(11), 839–849.
Scholar Publishing Houston, B., Thompson, M. C., Ko, A. L., & Chizeck, H. J. (2019). A machine-learning approach to volitional control of a closed-loop deep brain stimulation system. Journal of Neural Engineering, 16(1), 016004.
Ienca, M., & Andorno, R. (2017). Towards new human rights in the age of neuroscience. Life Sciences, Society and Policy, 13, 5.
Jorgensen, C., et al. (2003). Subvocal speech recognition. IEEE Proceedings.
Jumper, J., et al. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596,
Kapoor, A., & Picard, R. (2018). Silent speech interfaces. MIT Media Lab Publications.
Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019). Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine, 17, 195. https://doi.org/10.1186/s12916-019-1426-2
Kuhn, J., Gründler, T. O., Bauer, R., et al. (2014). Successful deep brain stimulation of the nucleus accumbens in severe alcohol dependence. Biological Psychiatry, 76(9), 734–742.
Langfelder, P., & Horvath, S. (2008). WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics, 9, 559.
Latourelle, J. C., Beste, M. T., Hadzi, T. C., et al. (2017). Large-scale identification of clinical and genetic predictors of motor progression in Parkinson’s disease. Movement Disorders, 32(10), 1514–1521.
Laver, K., et al. (2017). Virtual reality for stroke rehabilitation. Cochrane Database of Systematic Reviews.
LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436–444.
Lebedev, M. A., & Nicolelis, M. A. L. (2006). Brain–machine interfaces. Trends in Neurosciences, 29,
Li, X., Gu, Y., Dvornek, N., Staib, L. H., & Ventola, P. (2020). Multi-site fMRI analysis using privacypreserving federated learning. Medical Image Analysis, 65, 101765.
Litjens, G., Kooi, T., Bejnordi, B. E., et al. (2017). A survey on deep learning in medical image analysis. Medical Image Analysis, 42, 60–88.
Little, S., Pogosyan, A., Neal, S., et al. (2013). Adaptive deep brain stimulation in advanced Parkinson disease. Annals of Neurology, 74(3), 449–457.
Lyu, J., et al. (2019). Ultra-large library docking for discovering new chemotypes. Nature, 566,
Makin, J. G., et al. (2020). Machine translation of cortical activity to text. Nature Neuroscience, 23, 575–582.
McCarthy, J., Minsky, M. L., Rochester, N., & Shannon, C. E. (1955). A proposal for the Dartmouth summer research project on artificial intelligence.
Medtronic. (2025). CE mark approval for AlphaDBS closed-loop system. Medtronic Press Release.
Mitchell, T. M. (1997). Machine learning. McGraw-Hill.
Moses, D. A., et al. (2021). Neuroprosthesis for decoding speech in a paralyzed person. New England Journal of Medicine, 385, 217–227.
Scholar Publishing Neumann, W.-J., Staub-Bartelt, F., Horn, A., et al. (2018). Long-term correlation of subthalamic beta band activity with motor impairment in Parkinson’s disease. Clinical Neurophysiology, 129(3),
Ocaña, A., et al. (2023). Artificial intelligence in clinical trials: Synthetic control arms and digital twins. BMC Medicine, 21, 145.
OECD. (2019). Recommendation on responsible innovation in neurotechnology. OECD Publishing.
OpenAI. (2023). GPT-4 technical report. arXiv preprint arXiv:2303.08774.
Orrù, G., Pettersson-Yeo, W., Marquand, A., Sartori, G., & Mechelli, A. (2012). Using support vector machine to identify imaging biomarkers. Neuroscience & Biobehavioral Reviews, 36(4), 1140–1152.
Oxley, T. J., et al. (2016). Minimally invasive endovascular stent-electrode array. Nature Biotechnology, 34, 320–327.
Pandarinath, C., et al. (2017). High-performance communication by people with paralysis. eLife, 6, e18554.
Rajpurkar, P., Hannun, A. Y., Haghpanahi, M., et al. (2017). Cardiologist-level arrhythmia detection with convolutional neural networks. arXiv preprint.
Ramesh, A., Dhariwal, P., Nichol, A., et al. (2022). Hierarchical text-conditional image generation with CLIP latents. arXiv preprint.
Rieke, N., Hancox, J., Li, W., et al. (2020). The future of digital health with federated learning. NPJ Digital Medicine, 3, 119.
Rosa, M., Arlotti, M., Ardolino, G., et al. (2017). Adaptive deep brain stimulation in a freely moving Parkinsonian patient. Movement Disorders, 32(3), 371–375.
Rudin, C. (2019). Stop explaining black box machine learning models for high-stakes decisions. Nature Machine Intelligence, 1, 206–215.
Russell, S., & Norvig, P. (2021). Artificial intelligence: A modern approach (4th ed.). Pearson.
Schiff, N. D., Giacino, J. T., Kalmar, K., et al. (2007). Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature, 448, 600–603.
Schneider, G., et al. (2020). Artificial intelligence in drug discovery: Trends and prospects. Nature Reviews Drug Discovery, 19, 353–364.
Stokes, J. M., et al. (2020). A deep learning approach to antibiotic discovery. Cell, 180(4), 688–702.
Titano, J. J., Badgeley, M., Schefflein, J., et al. (2018). Automated deep-neural-network surveillance of cranial images. Nature Medicine, 24, 1337–1341.
Topol, E. J. (2019). Deep medicine: How artificial intelligence can make healthcare human again. Basic Books.
U.S. Food and Drug Administration (FDA). (2025). Approval summary: Adaptive deep brain stimulation system for Parkinson’s disease (ADAPT PD trial). FDA.
Vamathevan, J., et al. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18, 463–477.
Vaswani, A., et al. (2017). Attention is all you need. Advances in Neural Information Processing Systems.
Vieira, S., Pinaya, W. H. L., & Mechelli, A. (2017). Deep learning in neuroimaging. Neuroscience & Biobehavioral Reviews, 74, 58–75.
Willett, F. R., et al. (2023). A high-performance speech neuroprosthesis. Nature, 620, 103–109. Scholar Publishing
Wolpaw, J. R., et al. (2002). Brain–computer interfaces for communication and control. Clinical Neurophysiology, 113, 767–791.
Yang, D., Roth, H. R., Xu, Z., et al. (2018). Automatic brain tumor segmentation using convolutional neural networks. arXiv preprint.
Zhavoronkov, A., et al. (2019). Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nature Biotechnology, 37, 1038–1040.
Zhang, D., Wang, Y., Zhou, L., Yuan, H., & Shen, D. (2011). Multimodal classification of Alzheimer’s disease and mild cognitive impairment. NeuroImage, 55(3), 856–867.
Zhang, Y., et al. (2023). Graph neural networks for molecular property prediction and drug discovery. Briefings in Bioinformatics, 24(2), bbac515.
Zitnik, M., Agrawal, M., & Leskovec, J. (2019). Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics, 35(14), i457–i466.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Alok K Bandyopadhyay PhD RAC
This work is licensed under a Creative Commons Attribution 4.0 International License.
